The move follows Biovail’s termination of its promotional services agreement with Sciele Pharmaceuticals in October. Biovail chose to part company with Sciele following the latter’s acquisition by Shionogi & Co.
Related topics: Commercial Services
Biovail has said it intends to use a contract sales organisation to promote Zovirax, which it believes will allow it to “retain a greater share of the product line's economics”.
The move follows Biovail’s termination of its promotional services agreement with Sciele Pharmaceuticals in October. Biovail chose to part company with Sciele following the latter’s acquisition by Shionogi & Co.
Copyright - Unless otherwise stated all contents of this web site are © 2012 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions